PL4249456T3 - Radioznacznik i środek terapeutyczny wiążący psma o podwójnym działaniu - Google Patents
Radioznacznik i środek terapeutyczny wiążący psma o podwójnym działaniuInfo
- Publication number
- PL4249456T3 PL4249456T3 PL23167668.5T PL23167668T PL4249456T3 PL 4249456 T3 PL4249456 T3 PL 4249456T3 PL 23167668 T PL23167668 T PL 23167668T PL 4249456 T3 PL4249456 T3 PL 4249456T3
- Authority
- PL
- Poland
- Prior art keywords
- radiotracer
- therapeutic
- dual mode
- psma binding
- binding dual
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
- A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/008—Peptides; Proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
- Circuits Of Receivers In General (AREA)
- Nuclear Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Toys (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19154500 | 2019-01-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4249456T3 true PL4249456T3 (pl) | 2025-03-31 |
Family
ID=65268810
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL23167668.5T PL4249456T3 (pl) | 2019-01-30 | 2020-01-30 | Radioznacznik i środek terapeutyczny wiążący psma o podwójnym działaniu |
| PL20702636.0T PL3917626T3 (pl) | 2019-01-30 | 2020-01-30 | Dwutrybowy radioznacznik i terapeutyk wiążący psma |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20702636.0T PL3917626T3 (pl) | 2019-01-30 | 2020-01-30 | Dwutrybowy radioznacznik i terapeutyk wiążący psma |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US12357711B2 (pl) |
| EP (2) | EP4249456B1 (pl) |
| JP (2) | JP7528100B2 (pl) |
| KR (1) | KR102850587B1 (pl) |
| CN (2) | CN116675730A (pl) |
| AU (2) | AU2020213678B2 (pl) |
| BR (1) | BR112021014933A2 (pl) |
| CA (1) | CA3128401A1 (pl) |
| DK (2) | DK3917626T3 (pl) |
| EA (1) | EA202191691A1 (pl) |
| ES (2) | ES2953196T3 (pl) |
| FI (2) | FI3917626T3 (pl) |
| HU (2) | HUE063038T2 (pl) |
| IL (2) | IL303421A (pl) |
| MX (1) | MX2021008999A (pl) |
| PL (2) | PL4249456T3 (pl) |
| PT (2) | PT4249456T (pl) |
| SG (1) | SG11202108109RA (pl) |
| WO (1) | WO2020157177A1 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240027896A (ko) | 2017-07-28 | 2024-03-04 | 테크니쉐 우니베르지테트 뮌헨 | 이중 모드 방사성 트레이서 및 치료법 |
| WO2020157177A1 (en) * | 2019-01-30 | 2020-08-06 | Technische Universität München | Psma binding dual mode radiotracer and therapeutic |
| GB202005282D0 (en) | 2020-04-09 | 2020-05-27 | Blue Earth Diagnostics Ltd | Pharmaceutical Formulations |
| JP2023539990A (ja) * | 2020-07-13 | 2023-09-21 | ポイント バイオファーマ インコーポレイテッド | 放射性薬剤および方法 |
| EP4185336A1 (en) * | 2020-07-23 | 2023-05-31 | Technische Universität München | Silicon-containing ligand compounds |
| EP4023250A1 (en) * | 2021-01-04 | 2022-07-06 | Technische Universität München | Dual mode radiotracer and -therapeutics |
| IL305134A (en) * | 2021-02-15 | 2023-10-01 | Technische Universit?T M?Nchen | Dual mode radio and medical tracker |
| GB202109922D0 (en) | 2021-07-09 | 2021-08-25 | Blue Earth Diagnostics Ltd | Radiotracers and therapeutics binding to fibroblast activation protein (fap) |
| US20250313579A1 (en) * | 2021-08-05 | 2025-10-09 | Technische Universität München | Ligand compounds comprising a chelating group as a bridging group |
| GB202113646D0 (en) | 2021-09-24 | 2021-11-10 | Blue Earth Diagnostics Ltd | Method of preparation of 18F labelled silyl-fluoride compounds |
| US20230149569A1 (en) * | 2021-09-28 | 2023-05-18 | Antelope Surgical Solutions, Inc. | Multifunctional compounds for use in medical imaging and therapy |
| GB202207372D0 (en) | 2022-05-19 | 2022-07-06 | Blue Earth Diagnostics Ltd | Synthesis of fluorosilyl compounds |
| GB202316239D0 (en) | 2023-10-24 | 2023-12-06 | Blue Earth Diagnostics Ltd | Therapeutic combination |
| GB202318958D0 (en) * | 2023-12-12 | 2024-01-24 | King S College London | Compound |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7682601B2 (en) * | 2003-04-15 | 2010-03-23 | Mallinckrodt Inc. | Bifunctional tridentate pyrazolyl containing ligands for re and tc tricarbonyl complexes |
| CN1774268A (zh) * | 2003-04-15 | 2006-05-17 | 马林克罗特公司 | 用于铼和锝的三羰基络合物的双功能三齿的含吡唑基配体 |
| ES2684322T3 (es) * | 2006-11-08 | 2018-10-02 | Molecular Insight Pharmaceuticals, Inc. | Heterodímeros de ácido glutámico |
| JPWO2011040574A1 (ja) * | 2009-09-30 | 2013-02-28 | 国立大学法人京都大学 | アゼチジニルメトキシピリジン誘導体の製造方法及びその使用 |
| NZ612327A (en) * | 2010-12-22 | 2015-03-27 | Ge Healthcare Ltd | Her2 binding peptides labelled with a 18f - containing organosilicon compound |
| CN102626522B (zh) * | 2012-04-12 | 2014-09-10 | 韩彦江 | 基于趋化因子受体cxcr4多肽类拮抗剂的多肽放射性诊断与治疗药物 |
| AU2014336638C1 (en) * | 2013-10-18 | 2020-09-17 | Novartis Ag | Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer |
| EP3209336B1 (en) | 2014-10-20 | 2019-12-11 | Deutsches Krebsforschungszentrum | 18f-tagged inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer |
| KR102724812B1 (ko) * | 2017-04-05 | 2024-11-01 | 코넬 유니버시티 | 영상화 및 항종양 치료요법에 유용한 조정 가능한 약동학을 갖는 삼작용성 작제물 |
| KR20240027896A (ko) | 2017-07-28 | 2024-03-04 | 테크니쉐 우니베르지테트 뮌헨 | 이중 모드 방사성 트레이서 및 치료법 |
| DK3723815T3 (da) * | 2017-12-11 | 2022-07-11 | Univ Muenchen Tech | PSMA ligander til billeddannelse og endoradioterapi |
| WO2020157177A1 (en) * | 2019-01-30 | 2020-08-06 | Technische Universität München | Psma binding dual mode radiotracer and therapeutic |
-
2020
- 2020-01-30 WO PCT/EP2020/052248 patent/WO2020157177A1/en not_active Ceased
- 2020-01-30 DK DK20702636.0T patent/DK3917626T3/da active
- 2020-01-30 HU HUE20702636A patent/HUE063038T2/hu unknown
- 2020-01-30 ES ES20702636T patent/ES2953196T3/es active Active
- 2020-01-30 FI FIEP20702636.0T patent/FI3917626T3/fi active
- 2020-01-30 EA EA202191691A patent/EA202191691A1/ru unknown
- 2020-01-30 BR BR112021014933-3A patent/BR112021014933A2/pt unknown
- 2020-01-30 PL PL23167668.5T patent/PL4249456T3/pl unknown
- 2020-01-30 AU AU2020213678A patent/AU2020213678B2/en active Active
- 2020-01-30 PL PL20702636.0T patent/PL3917626T3/pl unknown
- 2020-01-30 JP JP2021544525A patent/JP7528100B2/ja active Active
- 2020-01-30 DK DK23167668.5T patent/DK4249456T3/da active
- 2020-01-30 US US17/426,962 patent/US12357711B2/en active Active
- 2020-01-30 CN CN202310616797.7A patent/CN116675730A/zh active Pending
- 2020-01-30 FI FIEP23167668.5T patent/FI4249456T3/fi active
- 2020-01-30 CA CA3128401A patent/CA3128401A1/en active Pending
- 2020-01-30 EP EP23167668.5A patent/EP4249456B1/en active Active
- 2020-01-30 IL IL303421A patent/IL303421A/en unknown
- 2020-01-30 HU HUE23167668A patent/HUE069264T2/hu unknown
- 2020-01-30 MX MX2021008999A patent/MX2021008999A/es unknown
- 2020-01-30 EP EP20702636.0A patent/EP3917626B1/en active Active
- 2020-01-30 KR KR1020217027178A patent/KR102850587B1/ko active Active
- 2020-01-30 IL IL284958A patent/IL284958B2/en unknown
- 2020-01-30 ES ES23167668T patent/ES2995872T3/es active Active
- 2020-01-30 CN CN202080024836.9A patent/CN113677400B/zh active Active
- 2020-01-30 PT PT231676685T patent/PT4249456T/pt unknown
- 2020-01-30 PT PT207026360T patent/PT3917626T/pt unknown
- 2020-01-30 SG SG11202108109RA patent/SG11202108109RA/en unknown
-
2023
- 2023-06-05 AU AU2023203501A patent/AU2023203501B2/en active Active
-
2024
- 2024-03-22 JP JP2024046097A patent/JP7763885B2/ja active Active
-
2025
- 2025-06-09 US US19/232,208 patent/US20250295819A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL284958B2 (en) | A two-state radioactive tracer binds PSMA and medical treatment | |
| IL278888A (en) | PSMA binding agents and their uses | |
| IL286079B2 (en) | History of Imidazolonylquinilines and their medical uses | |
| GB201802201D0 (en) | Binding agents | |
| IL291486B1 (en) | Therapeutic conjugates | |
| GB201711068D0 (en) | Therapeutic molecules binding PSMA | |
| IL289145A (en) | il1rap binding proteins | |
| GB201900702D0 (en) | Therapy | |
| GB201918541D0 (en) | Therapeutic compounds and their use | |
| GB201905520D0 (en) | Compounds and their therapeutic use | |
| PL3935441T3 (pl) | Kolimator | |
| IL304198A (en) | Radiotracer and-therapeutics with dual mode | |
| IL304317A (en) | tgf–beta–rii binding proteins | |
| GB201918752D0 (en) | New therapy | |
| GB201909493D0 (en) | Therapeutic interactions | |
| GB201912191D0 (en) | New therapy | |
| ZA202200734B (en) | Binding members | |
| GB201912657D0 (en) | Binding members | |
| GB201919286D0 (en) | Binding proteins | |
| GB201901704D0 (en) | Binding polypeptides | |
| HK40048186A (en) | Psma binding agents and uses thereof | |
| GB201916983D0 (en) | Therapy | |
| GB201914848D0 (en) | Therapy | |
| GB201913785D0 (en) | Therapy | |
| GB201913797D0 (en) | Therapy |